Vizsgálati helyszín

Saga University Hospital

Saga, Saga-ken 849-8501, JapánMég nincs intézményhez kötve

27futó vizsgálat
13lezárt vizsgálat

Az itteni vizsgálatok

Miről szól a helyszín 40 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek: Colitis ulcerosa13 vizsgálat
Crohn-betegség9 vizsgálat
Zsírmáj (MASLD/MASH)7 vizsgálat
Hemofília2 vizsgálat
Koszorúér-betegség2 vizsgálat
Krónikus gyulladásos demielinizációs polineuropátia (CIDP)2 vizsgálat
Liver cirrhosis2 vizsgálat
2-es típusú cukorbetegség1 vizsgálat
Akut limfoid leukémia (ALL)1 vizsgálat
Arthritis psoriatica1 vizsgálat
Deep vein thrombosis and pulmonary embolism1 vizsgálat
Glioblasztóma1 vizsgálat
és még 6
Fázis: 3. fázis27 vizsgálat
2. fázis10 vizsgálat
2/3. fázis2 vizsgálat
4. fázis1 vizsgálat
Állapot: Toboroz17 vizsgálat
Lezárult13 vizsgálat
Fut, nem toboroz10 vizsgálat
Fő szponzor: Janssen Research & Development, LLC8 vizsgálat
Pfizer5 vizsgálat
Eli Lilly and Company4 vizsgálat
Hoffmann-La Roche3 vizsgálat
Abivax S.A.2 vizsgálat
és még 15

Futó vizsgálatok

Toboroz
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07577856· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
NCT07165028· 3. fázis· Eli Lilly and Company· Forrás
Contact: Hirokazu Takahashi (principal investigator)
Toboroz
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
NCT07196722· 2/3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
NCT06979336· 2. fázis· Genentech, Inc.· Forrás
Toboroz
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630· 3. fázis· argenx· Forrás
Contact: Haruki Koike, MD
Toboroz
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004· 3. fázis· argenx· Forrás
Contact: Haruki Koike, MD
Toboroz
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
NCT07015905· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819878· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
NCT06632457· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
NCT06632444· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Fut, nem toboroz
A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06589986· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
NCT06226883· 2. fázis· Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)· Forrás
Contact: Nanae Tsuruoka (principal investigator)
Fut, nem toboroz
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
NCT06254950· 2. fázis· Takeda· Forrás
Toboroz
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
NCT05509777· 3. fázis· Eli Lilly and Company· Forrás
Contact: Toshihiko Kakiuchi (principal investigator)
Toboroz
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
NCT05923073· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
NCT06260163· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
NCT05702034· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
ABTECT - Maintenance
NCT05535946· 3. fázis· Abivax S.A.· Forrás
Toboroz
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
NCT05287126· 2. fázis· Pfizer· Forrás
Fut, nem toboroz
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus
NCT05648500· 3. fázis· Viatris Innovation GmbH· Forrás
Toboroz
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
NCT05611801· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
NCT05242471· 2. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
NCT05145127· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
NCT03950232· 3. fázis· Pfizer· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
NCT03178552· 2/3. fázis· Hoffmann-La Roche· Forrás
Toboroz
Phase III Trial of Stage I Ovarian Cancer After Surgery
NCT04063527· 3. fázis· Japanese Gynecologic Oncology Group· Forrás
Contact: Masatoshi Yokoyama

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Crohn-betegség6 toboroz
Colitis ulcerosa4 toboroz
Zsírmáj (MASLD/MASH)3 toboroz
Krónikus gyulladásos demielinizációs polineuropátia (CIDP)2 toboroz
Arthritis psoriatica1 toboroz
Deep vein thrombosis and pulmonary embolism1 toboroz
Hemofília1 toboroz
Liver cirrhosis1 toboroz
Petefészekrák1 toboroz
Pikkelysömör1 toboroz

Lezárt vizsgálatok

Lezárult
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis
NCT05784246· 3. fázis· Eli Lilly and Company· Forrás
Lezárult
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás
Lezárult
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
NCT05507216· 3. fázis· Abivax S.A.· Forrás
Lezárult
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis
NCT05327127· 2. fázis· Kowa Research Institute, Inc.· Forrás
Lezárult
Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
NCT04971785· 2. fázis· Gilead Sciences· Forrás
Lezárult
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
NCT04321031· 2. fázis· Pfizer· Forrás
Lezárult
A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
NCT04397263· 3. fázis· Janssen Pharmaceutical K.K.· Forrás
Lezárult
Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma
NCT04102150· 2. fázis· Daiichi Sankyo Co., Ltd.· Forrás
Lezárult
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
NCT04166773· 2. fázis· Eli Lilly and Company· Forrás
Lezárult
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
NCT02914535· 3. fázis· Alfasigma S.p.A.· Forrás
Lezárult
Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III
NCT02761070· 3. fázis· Kyorin University· Forrás
Lezárult
A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease
NCT02620046· 3. fázis· Takeda· Forrás
Lezárult
Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease
NCT01422421· 4. fázis· Takeshi Morimoto· Forrás

Helyszínadatok: ClinicalTrials.govFrissítve: 2026. nov. 15.

Hibát jelzek